Implante de prótesis aórtica transcatéter en insuficiencia aórtica no calcificada. ¿En qué punto estamos?

  1. Ignacio Amat Santos 1
  2. Juan Pablo Sánchez Luna 1
  1. 1 Servicio de Cardiología, Hospital Clínico Universitario, Valladolid, España
Zeitschrift:
REC: Interventional Cardiology

ISSN: 2604-7276,  2604-7306

Datum der Publikation: 2024

Ausgabe: 6

Nummer: 1

Seiten: 3-6

Art: Artikel

DOI: 10.24875/RECIC.M23000421 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Andere Publikationen in: REC: Interventional Cardiology

Ziele für nachhaltige Entwicklung

Bibliographische Referenzen

  • 1. Santos-Martínez S, Amat-Santos IJ. New Challenging Scenarios in Transcatheter Aortic Valve Implantation:Valve-in-valve, Bicuspid and Native Aortic Regurgitation. Eur Cardiol. 2021;16:e29.
  • 2. Maurer G. Aortic regurgitation. Heart. 2006;92:994-1000.
  • 3. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention. 2022;17:e1126-e1196.
  • 4. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease:Executive Summary:A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e35-e71.
  • 5. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83:897-902.
  • 6. Adam M, Tamm AR, Wienemann H, et al. Transcatheter Aortic Valve Replacement for Isolated Aortic Regurgitation Using a New Self-Expanding TAVR System. JACC Cardiovasc Interv. 2023;16:1965-1973.
  • 7. Garcia S, Ye J, Webb J, et al. Transcatheter treatment of native aortic valve regurgitation:The North American Experience with a Novel Device. JACC Cardiovasc Interv. 2023;16:1953-1960.
  • 8. Chen Y, Zhao J, Liu Q, et al. Computed tomography anatomical characteristics based on transcatheter aortic valve replacement in aortic regurgitation. Int J Cardiovasc Imaging. 2023;39:2063–2071.
  • 9. D'Ancona G, Pasic M, Buz, S, et al. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device. Ann Thorac Surg. 2012;93:e89-e91.
  • 10. Takagi H, Hari Y, Kawai N, et al. Meta-analysis and meta-regression of transcatheter aortic valve implantation for pure native aortic regurgitation. Heart Lung Circ. 2020;29:729-741.
  • 11. Sánchez-Luna JP, Martin P, Dager AE, et al. Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation. EuroIntervention. 2023;19:580-588.
  • 12. Poletti E, De Backer O, Scotti A, et al. Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation:The PANTHEON International Project. JACC Cardiovasc Interv. 2023;16:1974-1985
  • 13. Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. J Am Coll Cardiol. 2017;70:2752-2763.
  • 14. De Backer O, Pilgrim T, Simonato M, et al. Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve Regurgitation. Am J Cardiol. 2018;122:1028-1035.
  • 15. Sawaya FJ, Deutsch MA, Seiffert M, et al. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses:Results From an International Registry Study. JACC Cardiovasc Interv. 2017;10:1048-1056.
Fuente de los datos: Dialnet